Wimmer Associates 1’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $305K | Hold |
4,425
| – | – | 0.16% | 94 |
|
|
2025
Q1 | $289K | Sell |
4,425
-360
| -8% | -$23.5K | 0.15% | 95 |
|
|
2024
Q4 | $412K | Sell |
4,785
-1,690
| -26% | -$145K | 0.2% | 79 |
|
|
2024
Q3 | $771K | Buy |
6,475
+160
| +3% | +$19.1K | 0.38% | 61 |
|
|
2024
Q2 | $901K | Hold |
6,315
| – | – | 0.46% | 51 |
|
|
2024
Q1 | $811K | Buy |
6,315
+35
| +0.6% | +$4.49K | 0.43% | 58 |
|
|
2023
Q4 | $650K | Buy |
6,280
+1,530
| +32% | +$158K | 0.37% | 66 |
|
|
2023
Q3 | $432K | Buy |
4,750
+850
| +22% | +$77.3K | 0.27% | 80 |
|
|
2023
Q2 | $316K | Buy |
3,900
+100
| +3% | +$8.09K | 0.19% | 91 |
|
|
2023
Q1 | $322K | Hold |
3,800
| – | – | 0.21% | 88 |
|
|
2022
Q4 | $257K | Sell |
3,800
-380
| -9% | -$25.7K | 0.17% | 98 |
|
|
2022
Q3 | $227K | Hold |
4,180
| – | – | 0.15% | 104 |
|
|
2022
Q2 | $233K | Sell |
4,180
-350
| -8% | -$19.5K | 0.15% | 102 |
|
|
2022
Q1 | $252K | Buy |
+4,530
| New | +$252K | 0.14% | 108 |
|
|
2017
Q1 | – | Sell |
-68,940
| Closed | -$1.24M | – | 112 |
|
|
2016
Q4 | $1.24M | Sell |
68,940
-21,090
| -23% | -$378K | 1.15% | 36 |
|
|
2016
Q3 | $1.87M | Sell |
90,030
-1,570
| -2% | -$32.6K | 1.69% | 18 |
|
|
2016
Q2 | $2.46M | Sell |
91,600
-90
| -0.1% | -$2.42K | 2.2% | 9 |
|
|
2016
Q1 | $2.48M | Buy |
91,690
+3,280
| +4% | +$88.9K | 2.28% | 9 |
|
|
2015
Q4 | $2.57M | Buy |
+88,410
| New | +$2.57M | 2.69% | 3 |
|